Guardant Health, Inc.
GH
$161.99
$9.646.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.20% | 12.78% | -38.58% | 7.18% | -4.98% |
| Total Depreciation and Amortization | 1.26% | -6.05% | 6.82% | -6.31% | -1.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.25% | 0.84% | 17.11% | 2.47% | 9.31% |
| Change in Net Operating Assets | 38.72% | -172.07% | 1,128.38% | 84.49% | 13.27% |
| Cash from Operations | 11.95% | -148.83% | 25.53% | 41.26% | 3.83% |
| Capital Expenditure | -110.73% | 79.96% | -169.06% | -83.22% | -26.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.94% | 186.16% | -20,355.78% | 20.00% | -101.63% |
| Cash from Investing | -85.49% | 177.28% | -6,207.09% | -34.75% | -103.52% |
| Total Debt Issued | -- | -- | 7,801.99% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 674.80% | -99.00% | 9,684.52% | -59.72% | 1,102.73% |
| Repurchase of Common Stock | 59.71% | -285.84% | -136.29% | 69.48% | 87.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 166.51% | 81.06% | -1,021.67% | -1,022.40% | 97.30% |
| Cash from Financing | 206.66% | -102.95% | 16,802.05% | 166.69% | 102.43% |
| Foreign Exchange rate Adjustments | -111.86% | 71.72% | -28.71% | -156.88% | 21.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.17% | 405.86% | -335.33% | 32.77% | -139.27% |